Rare neuroinflammatory or neuroimmunological disease

Rare neuroinflammatory or neuroimmunological diseases represent a broad category of uncommon disorders characterized by immune-mediated inflammation affecting the central and/or peripheral nervous system. As classified under Orphanet code 182064, this is a grouping designation rather than a single disease entity, encompassing a range of conditions in which the body's immune system mistakenly targets components of the nervous system, including the brain, spinal cord, optic nerves, and peripheral nerves. These conditions can manifest with a wide variety of neurological symptoms depending on the specific structures affected. Common clinical features across this group may include motor deficits (weakness, paralysis), sensory disturbances (numbness, tingling, pain), visual impairment, cognitive dysfunction, seizures, ataxia, and autonomic dysfunction. Some conditions within this category follow a relapsing-remitting course, while others may be monophasic or chronically progressive. The underlying pathophysiology typically involves autoantibody-mediated damage, T-cell-mediated inflammation, or other dysregulated immune responses directed against neural antigens such as myelin, neuronal surface proteins, or astrocytic components. Treatment approaches for rare neuroinflammatory and neuroimmunological diseases generally focus on immunosuppression and immunomodulation. Acute episodes are often managed with high-dose corticosteroids, plasma exchange (plasmapheresis), or intravenous immunoglobulin (IVIG). Long-term disease management may involve maintenance immunosuppressive therapies such as azathioprine, mycophenolate mofetil, rituximab, or other targeted biologic agents. Early diagnosis and treatment are critical to minimizing irreversible neurological damage. Given the rarity and heterogeneity of these conditions, management is best guided by specialists in neuroimmunology, and patients may benefit from multidisciplinary care teams.

Common questions about Rare neuroinflammatory or neuroimmunological disease